NeuroBo Pharmaceuticals Share Holder Equity 1970-1969 | MTVA
NeuroBo Pharmaceuticals share holder equity from 1970 to 1969. Share holder equity can be defined as the sum of preferred and common equity items
NeuroBo Pharmaceuticals Annual Share Holder Equity
(Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
